Fisman E, Westermeier F, Santulli G
Cardiovasc Diabetol. 2025; 24(1):30.
PMID: 39844290
PMC: 11755897.
DOI: 10.1186/s12933-025-02602-1.
Munoz-Galan H, Enshaei H, Silva J, Esteves T, Ferreira F, Casanovas J
ACS Appl Polym Mater. 2025; 6(14):8093-8104.
PMID: 39839886
PMC: 11745422.
DOI: 10.1021/acsapm.4c00911.
Shi S, Li X, Chen Y, Li J, Dai Y
J Diabetes. 2025; 17(1):e70044.
PMID: 39789833
PMC: 11717902.
DOI: 10.1111/1753-0407.70044.
Ghosh A, Debnath S, Igamberdiev A
Front Mol Biosci. 2025; 11:1520661.
PMID: 39758282
PMC: 11695640.
DOI: 10.3389/fmolb.2024.1520661.
Rajaragupathy S, Ponnusamy D, Balasundararaj D, Venkatesan S, Karthikeyan J
J Family Med Prim Care. 2024; 13(11):5240-5243.
PMID: 39722928
PMC: 11668435.
DOI: 10.4103/jfmpc.jfmpc_989_24.
Cardiologists vs Endocrinologists in Glycemic Control for Coronary Artery Disease Patients with Type 2 Diabetes: A Cross-Sectional Study.
Xia Q, Peng Q, Chen H, Zhang W
J Multidiscip Healthc. 2024; 17:5715-5723.
PMID: 39649367
PMC: 11624691.
DOI: 10.2147/JMDH.S494004.
Chronobiological disruptions: unravelling the interplay of shift work, circadian rhythms, and vascular health in the context of stroke risk.
Li X, He Y, Wang D, Momeni M
Clin Exp Med. 2024; 25(1):6.
PMID: 39541048
PMC: 11564290.
DOI: 10.1007/s10238-024-01514-w.
Potential pathogenic roles of ferroptosis and cuproptosis in cadmium-induced or exacerbated cardiovascular complications in individuals with diabetes.
Saedi S, Tan Y, Watson S, Wintergerst K, Cai L
Front Endocrinol (Lausanne). 2024; 15:1461171.
PMID: 39415790
PMC: 11479913.
DOI: 10.3389/fendo.2024.1461171.
Diabetes and Its Impact on Cardiogenic Shock Outcomes in Acute Myocardial Infarction with Polyvascular Disease: A Comparative Analysis.
Gatuz M, Abu-Fanne R, Abramov D, Mamas M, Roguin A, Kobo O
Biomedicines. 2024; 12(8).
PMID: 39200364
PMC: 11351229.
DOI: 10.3390/biomedicines12081900.
Monitoring Risk Factors and Improving Adherence to Therapy in Patients With Chronic Kidney Disease (Smit-CKD Project): Pilot Observational Study.
Vilasi A, Panuccio V, Morante S, Villa A, Versace M, Mezzatesta S
JMIR Bioinform Biotechnol. 2024; 3(1):e36766.
PMID: 38935948
PMC: 11135230.
DOI: 10.2196/36766.
Abnormal blood pressure dipping pattern: frequency, determinants, and correlates in Diabetes Mellitus patients in the Cardiovascular Health Risk Assessment in Diabetes Mellitus (CHiD) study.
Akintunde A, Olamoyegun M, Akinlade M, Yusuf O, Salawu A
J Diabetes Metab Disord. 2024; 23(1):689-697.
PMID: 38932843
PMC: 11196480.
DOI: 10.1007/s40200-023-01337-8.
ApoA1/HDL-C ratio as a predictor for coronary artery disease in patients with type 2 diabetes: a matched case-control study.
Ghaemi F, Rabizadeh S, Yadegar A, Mohammadi F, Asadigandomani H, Arab Bafrani M
BMC Cardiovasc Disord. 2024; 24(1):317.
PMID: 38914982
PMC: 11194875.
DOI: 10.1186/s12872-024-03986-w.
The long-term cost-effectiveness of once-weekly semaglutide versus sitagliptin for the treatment of type 2 diabetes in China.
Gu S, Gu J, Wang X, Wang X, Li L, Gu H
Health Econ Rev. 2024; 14(1):26.
PMID: 38564113
PMC: 10988849.
DOI: 10.1186/s13561-024-00499-2.
Effects of Liraglutide, Empagliflozin and Their Combination on Left Atrial Strain and Arterial Function.
Katogiannis K, Thymis J, Kousathana F, Pavlidis G, Korakas E, Kountouri A
Medicina (Kaunas). 2024; 60(3).
PMID: 38541121
PMC: 10971983.
DOI: 10.3390/medicina60030395.
Time-frequency analysis reveals an association between the specific nuclear magnetic resonance (NMR) signal properties of serum samples and arteriosclerotic lesion progression in a diabetes mouse model.
Yui K, Kanawaku Y, Morita A, Hirakawa K, Cui F
PLoS One. 2024; 19(3):e0299641.
PMID: 38457384
PMC: 10923453.
DOI: 10.1371/journal.pone.0299641.
Safety and efficacy of glucagon-like peptide-1 receptor agonists among kidney transplant recipients: a systematic review and meta-analysis.
Krisanapan P, Suppadungsuk S, Sanpawithayakul K, Thongprayoon C, Pattharanitima P, Tangpanithandee S
Clin Kidney J. 2024; 17(2):sfae018.
PMID: 38410684
PMC: 10896177.
DOI: 10.1093/ckj/sfae018.
Association of carotid atherosclerosis markers with all-cause and cardiovascular disease-specific mortality in persons with type 2 diabetes: a causal mediation analysis with glucose variation.
Lin C, Li C, Liu C, Lin C, Yang S, Li T
Acta Diabetol. 2024; 61(5):657-669.
PMID: 38393346
DOI: 10.1007/s00592-024-02243-y.
Inverse relationship between platelet Akt activity and hippocampal atrophy: A pilot case-control study in patients with diabetes mellitus.
Tokuda H, Hori T, Mizutani D, Hioki T, Kojima K, Onuma T
World J Clin Cases. 2024; 12(2):302-313.
PMID: 38313640
PMC: 10835682.
DOI: 10.12998/wjcc.v12.i2.302.
Safety and Efficacy of GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus with Advanced and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis.
Krisanapan P, Sanpawithayakul K, Pattharanitima P, Thongprayoon C, Miao J, Mao M
Diseases. 2024; 12(1).
PMID: 38248365
PMC: 10814593.
DOI: 10.3390/diseases12010014.
Association of periodontitis and tooth loss with extent of coronary atherosclerosis in patients with type 2 diabetes mellitus.
Shen M, Li Z, Li H, Yan X, Feng B, Xu L
Front Endocrinol (Lausanne). 2023; 14:1243992.
PMID: 38075042
PMC: 10702216.
DOI: 10.3389/fendo.2023.1243992.
